Osoba D
Quality of Life Committee, Clinical Trials Group, National Cancer Institute of Canada, Vancouver, BC.
Qual Life Res. 1992 Jun;1(3):211-8. doi: 10.1007/BF00635620.
The Quality of Life Committee of the National Cancer Institute of Canada Clinical Trials Group has successfully advocated the adoption of quality of life outcomes in Canadian clinical trials in patients with cancer. It has developed a policy promoting quality of life assessment in phase III trials and developed writing guidelines to assist clinical investigators when developing protocols for proposed studies. As a result, all phase III clinical trials instituted since the policy was developed have quality of life assessment as a part of their objectives. It has assisted the Clinical Trials Group office personnel in the development of procedures for the conduct of quality of life assessments in clinical trials with the result that the completion rate of self-report questionnaires is very high. The Committee maintains contact with other clinical trials groups and organizations having an interest in measuring quality of life in cancer.
加拿大国立癌症研究所临床试验组生活质量委员会已成功推动在加拿大癌症患者临床试验中采用生活质量指标。该委员会制定了一项政策，促进在III期试验中进行生活质量评估，并制定了撰写指南，以协助临床研究人员在制定拟议研究方案时参考。因此，自该政策制定以来开展的所有III期临床试验都将生活质量评估作为其目标的一部分。该委员会协助临床试验组办公室人员制定在临床试验中进行生活质量评估的程序，结果自我报告问卷的完成率非常高。该委员会与其他对测量癌症患者生活质量感兴趣的临床试验组和组织保持联系。
